Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business
  • Functional Area Sort descending
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Functional Area Sort descending Erscheinungsdatum
Sr. Manager, ITOT Site Lead Haiyan (Zhejiang Province) China Operations CTS Technology Transformation Sep 03, 2024
Associate Director(SAP SD S/4Hana) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Director - Enterprise Architect, APD Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Assoc. Dir. Platform Analytics Architecture Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Regulatory Affairs Systems & Strategy Manager London (The Westworks) Vereinigtes Königreich Development Innovative Medicines Technology Transformation Sep 02, 2024
Solution Architect - Corporate Functions Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 10, 2024
Enterprise Architecture and Integrations Director - Americas INSURGENTES Mexiko Operations CTS Technology Transformation Sep 10, 2024
Associate Director - LAN Sol. Architect (CZ, Spain, Mexico) Prague Tschechische Republik Operations CTS Technology Transformation Sep 11, 2024
Sr. Specialist Qualification Engineer INSURGENTES Mexiko Operations CTS Technology Transformation Sep 11, 2024
Sr. Specialist (SAP Business Process Automation) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 13, 2024
Business Analyst – Biomedical research with Generative AI Expertise Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 13, 2024
Assoc. Director- Solutions Delivery (SAP Business Process Automation) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 13, 2024
Associate Director, Global Function Finance DDIT Head Office (Japan) (Pharmaceuticals) Japan Operations CTS Technology Transformation Sep 04, 2024
Associate Director Enterprise Architect -IAM Barcelona Gran Vía Spanien Operations CTS Technology Transformation Sep 04, 2024
Associate Director OPX Planning Prague Tschechische Republik Operations CTS Technology Transformation Sep 06, 2024
Business process expert - Life Sciences(Regulatory, CSR, PV) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 09, 2024
Associate Director – Conferencing Platform Services INSURGENTES Mexiko Operations CTS Technology Transformation Sep 09, 2024
Enterprise Architecture and Integration Director for Commercial Areas INSURGENTES Mexiko Operations CTS Technology Transformation Jun 04, 2024
Assoc. Dir. DDIT APD ERP Commercials and Cross Functional Santo Amaro Brasilien Operations CTS Technology Transformation Sep 03, 2024
Senior Security Architect - Commercial areas INSURGENTES Mexiko Operations CTS Technology Transformation Jun 19, 2024
Associate Director - IT Project/Program Manager Prague Tschechische Republik Operations CTS Technology Transformation Sep 03, 2024
Network Security Engineer - Firewall Services INSURGENTES Mexiko Operations CTS Technology Transformation Jun 25, 2024
Senior Business Analyst DDIT US&I JP&APMA (Japanese Speaker) Selangor Malaysia Operations CTS Technology Transformation Jul 01, 2024
Agile Project Management Lead Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Technology Transformation Jul 01, 2024
Specialist Resource Management Prague Tschechische Republik Operations CTS Technology Transformation Jul 08, 2024
Specialist, Master Batch Record (MBR) Design Millburn USA Operations CTS Technology Transformation Jul 09, 2024
Veeva CRM Architect Barcelona Gran Vía Spanien Operations CTS Technology Transformation Sep 03, 2024
Specialist, Master Batch Record (MBR) Design Indianapolis USA Operations CTS Technology Transformation Sep 03, 2024
Functional Design Architect - SAP Barcelona Gran Vía Spanien Operations CTS Technology Transformation Sep 03, 2024
Sr.Specialist – Wireless Network Engineering INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Network Specialist INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Network Specialist INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Specialist – Wireless Network Engineering INSURGENTES Mexiko Operations CTS Technology Transformation Jul 16, 2024
Private Cloud, Service Delivery Manager Prague Tschechische Republik Operations CTS Technology Transformation Jul 17, 2024
Specialist - Mobile Device Management (MDM) Engineer Prague Tschechische Republik Operations CTS Technology Transformation Jul 17, 2024
Junior Engineer - Conferencing (AR / VR platforms) Prague Tschechische Republik Operations CTS Technology Transformation Jul 22, 2024
Associate Director for Records & Information Management (Information Security and Compliance) Prague Tschechische Republik Operations CTS Technology Transformation Jul 23, 2024
Associate Director -Project Manager LDC Operations( SAP S4Hana SCM Applications) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 16, 2024
Sr. Spec. DDIT IES NetSec Engg Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC Ent Arch Digit Sec Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC VulnSvcs role Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 17, 2024
Sr. Bus. Analyst DDIT US&I CPM Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 17, 2024
Mgr. DDIT Svc.Mgt China Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Svc.Mgt CN Data Platf Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Sol.Del. China Data Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Spec. DDIT IES NW Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 22, 2024
Snr.Spec. DDIT APD Sol Del Visualization Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 22, 2024
Sr. Specialist DDIT APD ERP PlatformTech Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 23, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.